Efficacy and safety evaluation of a combination of iguratimod and methotrexate therapy for active rheumatoid arthritis patients: a randomized controlled trial

Controlled Trial ◽

Safety Evaluation ◽

Methotrexate Therapy ◽

Efficacy And Safety ◽

A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy

Arthritis Research & Therapy ◽

10.1186/s13075-018-1646-4 ◽

2018 ◽

Vol 20 (1) ◽

Cited By ~ 22

Author(s):

Stanley B. Cohen ◽

Rieke Alten ◽

Hideto Kameda ◽

Tomas Hala ◽

Sebastiao C. Radominski ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Reference Product ◽

Controlled Trial ◽

Methotrexate Therapy ◽

Comparison of the efficacy and safety of two starting dosages of prednisolone in early active rheumatoid arthritis (CORRA): study protocol for a randomized controlled trial

Trials ◽

10.1186/1745-6215-15-344 ◽

2014 ◽

Vol 15 (1) ◽

Cited By ~ 4

Author(s):

Ulrike S Trampisch ◽

Dietmar Krause ◽

Hans J Trampisch ◽

Renate Klaassen-Mielke ◽

Xenofon Baraliakos ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Study Protocol ◽

Controlled Trial ◽

Efficacy And Safety ◽

SAT0476 Impact of etanercept-methotrexate therapy on patient-reported outcomes in a randomized controlled trial in moderately active rheumatoid arthritis patients:

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-eular.3422 ◽

2013 ◽

Vol 71 (Suppl 3) ◽

pp. 633.2-633

Author(s):

P. Bird ◽

J. Wollenhaup ◽

S.-H. Lee ◽

Z. Szekanecz ◽

O. Neira ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Patient Reported Outcomes ◽

Controlled Trial ◽

Methotrexate Therapy ◽

Randomized Controlled ◽

Patient Reported

Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy

International Journal of Rheumatic Diseases ◽

10.1111/1756-185x.12723 ◽

2015 ◽

Vol 19 (11) ◽

pp. 1143-1156 ◽

Cited By ~ 3

Author(s):

Zhanguo Li ◽

Fengchun Zhang ◽

Jonathan Kay ◽

Kaiyin Fei ◽

Chenglong Han ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Controlled Trial ◽

Methotrexate Therapy ◽

Chinese Patients ◽

Efficacy And Safety ◽

Phase 3

The Effect of Puerarin on Carotid Intima-media Thickness in Patients With Active Rheumatoid Arthritis: A Randomized Controlled Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2018.08.014 ◽

2018 ◽

Vol 40 (10) ◽

pp. 1752-1764.e1 ◽

Cited By ~ 3

Author(s):

Min Yang ◽

Yong Luo ◽

Tao Liu ◽

Xiaolong Zhong ◽

Jiao Yan ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Controlled Trial ◽

Intima Media Thickness ◽

Carotid Intima Media Thickness ◽

Randomized Controlled ◽

Media Thickness

Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: Results from a randomized controlled trial

Arthritis & Rheumatism ◽

10.1002/art.30194 ◽

2011 ◽

Vol 63 (3) ◽

pp. 622-632 ◽

Cited By ~ 50

Author(s):

Maria W. Greenwald ◽

William J. Shergy ◽

Jeffrey L. Kaine ◽

Marianne T. Sweetser ◽

Kye Gilder ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Controlled Trial ◽

Tumor Necrosis Factor Inhibitor ◽

Randomized Controlled ◽

Factor Inhibitor ◽

Necrosis Factor

FRI0128 A NOVEL FORMULATION OF CT-P13 (INFLIXIMAB BIOSIMILAR) FOR SUBCUTANEOUS ADMINISTRATION: 1-YEAR RESULTS FROM A PART 1 OF PHASE I/III RANDOMIZED CONTROLLED TRIAL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS

10.1136/annrheumdis-2019-eular.1094 ◽

2019 ◽

Cited By ~ 1

Author(s):

DaeHyun Yoo ◽

Janusz Jaworski ◽

Ewa Matyska-Piekarska ◽

Svitlana Smiyan ◽

Delina Ivanova ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Phase I ◽

Controlled Trial ◽

Subcutaneous Administration ◽

Function and health-related quality of life: Results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis

Arthritis & Rheumatism ◽

10.1002/1529-0131(199909)42:9<1870::aid-anr11>3.0.co;2-d ◽

1999 ◽

Vol 42 (9) ◽

pp. 1870-1878 ◽

Cited By ~ 67

Author(s):

Vibeke Strand ◽

Peter Tugwell ◽

Claire Bombardier ◽

Andreas Maetzel ◽

Bruce Crawford ◽

...

Keyword(s):

Quality Of Life ◽

Rheumatoid Arthritis ◽

Controlled Trial ◽

Health Related Quality ◽

Randomized Controlled ◽

Related Quality ◽

Health Related

Faculty Opinions recommendation of Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: results from a randomized controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9664956.10337054 ◽

2011 ◽

Author(s):

Ulf Müller-Ladner

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Controlled Trial ◽

Tumor Necrosis Factor Inhibitor ◽

Randomized Controlled ◽

Factor Inhibitor ◽

Necrosis Factor

Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: A randomized, controlled trial

Arthritis & Rheumatism ◽

10.1002/art.20167 ◽

2004 ◽

Vol 50 (2) ◽

pp. 364-371 ◽

Cited By ~ 48

Author(s):

C. Michael Lambert ◽

Sharron Sandhu ◽

Alison Lochhead ◽

Nigel P. Hurst ◽

Euan McRorie ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Dose Escalation ◽

Controlled Trial ◽